Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy

Autor: Ravaud, A, Motzer, Rj, Pandha, Hs, George, Dj, Pantuck, Aj, Patel, A, Chang, Yh, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Breza, J, Gerletti, P, Lechuga, M1, Lin, X, Martini, Jf, Ramaswamy, K, Casey, M, Staehler, M, Patard, Jj, Gruenwald, V, Link, K, Doehn, C, Heinzer, H, Grimm, M-O, Wirth, M, Stoeckle, M, Heidenreich, A, Garcia del Muro Solans, X, Mellado, Bo, Castellano, Dg, Frydenberg, M, Schobinger, Sr, Dimopoulos, Ma, Rothermundt, C, Climent Duran MA, Melotti, B, Procopio, G, Boccardo, F, Sella, A, Stewart, S, Adenis, A, Jones, Rj, Chevreau, C, Prausova, J, Vyzula, R, Oudard, S, Jacqmin, D, Gravis, G, Varela, R, Herrmann, E, Lim, Hy, Lee, J-L, Kim, Yh, Kim, Jh, Y-C, Ou, Papakotoulas, P, Iacobelli, S, Chowdhury, S, Passalacqua, R, Tomasek, J, Anton Aparicio LM, Linassier, C, Hauser, S, Bergmann, L, Hawkins, Re, Szczylik, C, Zdrojowy, R, Sosnowski, M, Koralewski, P, Wiechnio, Pj, Schraml, J, Mardiak, J, Laurinc, P, Kliment, J, Rosenbaum, E, Lundstam, S, Flodgren, P, Ljungberg, B, Stenzl, A, Schnoeller, Tj, Mcdermott, Sr, Breathnach, Os, Mccaffrey, Ja, Donnellan, P, The, G-C, Rolland, F, Brekkan, E, Nilsson, C, Kim, Wy, Bishoff, J, Chung, J, Shore, Nd, Master, V, Tang Chen DY, Ye, D, Huang, Y, Jin, J, Song, B, Zhou, F, Galceran, Jc, Yao, X, Zhang, X.

Publikováno v: Ravaud, A, Motzer, R J, Pandha, H S, George, D J, Pantuck, A J, Patel, A, Chang, Y-H, Escudier, B, Donskov, F, Magheli, A, Carteni, G, Laguerre, B, Tomczak, P, Gerletti, P, Lechuga, M, Lin, X, Martini, J-F, Ramaswamy, K, Casey, M, Staehler, M, Patard, J-J & S-TRAC Investigators 2016, ' Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy ', The New England Journal of Medicine, vol. 375, no. 23, pp. 2246-2254 . https://doi.org/10.1056/NEJMoa1611406

BACKGROUNDSunitinib, a vascular endothelial growth factor pathway inhibitor, is an effectivetreatment for metastatic renal-cell carcinoma. We sought to determine the efficacyand safety of sunitinib in patients with locoregional renal-cell carcinoma a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::044148e0163ba78bfbd9d2be3de578c8
https://surrey.eprints-hosting.org/812586/

Variation in Prostate Cancer Treatment Across the State of Utah—Impact of Population Density on Primary Treatment Modality

Autor: Gruhl, J.D., Francis, S., Lee, R.J., Sparenborg, J., Bishoff, J., Sause, W.T.

Publikováno v: In International Journal of Radiation Oncology, Biology, Physics 1 September 2019 105(1) Supplement:E468-E469

Seminal Vescicle Deseas

Autor: Moore, R, Bishoff, J, Loening, S, Docimo, S, Bove, P, Micali, S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3667::adc5c3e3269af361ebc250457e141f12
http://hdl.handle.net/2108/66879

Robotic telemanipulation for percutaneous renal access

Autor: Stoianovici, D., Lee, B. R., Bishoff, J. T., Micali, Salvatore, Whitcomb, L. L., Taylor, R. H., Kavoussi, L. R.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3674::8c27f6da24aaaeb4ca15763dec434767
https://hdl.handle.net/11380/826496

Utiliy of armonic scalpel for laparoscopic partial nephrectomy: correlation with the extent of resection

Autor: Cadeddu, J. A., Chen, R. N., Micali, Salvatore, Bishoff, J. T., Lee, B., Jackman, S., Moore, R. G., Kavoussi, L. R.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3674::eb9875f0e34b61bc5c76be05c897864c
https://hdl.handle.net/11380/825889